0000000000775486

AUTHOR

Marcos Ballester

showing 2 related works from this author

Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by int…

2020

International audience; Introduction The aim of this study was to identify prognostic factors of overall survival in patients with FIGO stage IIIc or IVa ovarian cancer (OC) treated by neo-adjuvant chemotherapy (NAC) followed by interval debulking surgery.Materials and methods Data from 483 patients with ovarian cancer were retrospectively collected, from January 1, 2000 to December 31, 2016, from the FRANCOGYN database, regrouping data from 11 centers specialized in ovarian cancer treatment. Median overall survival was determined using the Kaplan-Meier method. Univariate and multivariate analysis were performed to define prognostic factors of overall survival.Results The median overall sur…

Neoplasm Residualmedicine.medical_treatmentGenes BRCA2FIGO Stage IIICGenes BRCA1Platinum CompoundsCarcinoma Ovarian EpithelialCohort Studies0302 clinical medicineAscitic FluidOverall survivalPeritoneal Lavage030212 general & internal medicineOvarian NeoplasmsUnivariate analysisCytoreduction Surgical ProceduresGeneral MedicineMiddle AgedPrognosisDebulkingNeoadjuvant Therapy3. Good healthSurvival RateOncology030220 oncology & carcinogenesisFemaleTaxoidsFranceOmentumCohort studymedicine.medical_specialty[SDV.CAN]Life Sciences [q-bio]/CancerAntineoplastic Agents[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetricsInterval debulking surgeryNeoadjuvant chemotherapyPelvis03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancerOvarian cancerMedian follow-upmedicineHumansNeoplasm InvasivenessAgedNeoplasm StagingProportional Hazards Modelsbusiness.industryRetrospective cohort studymedicine.diseaseSurgery[SDV.MHEP.GEO] Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieMultivariate AnalysisLymph Node Excision[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSurgeryLymphadenectomyLymph NodesOvarian cancerbusinessEuropean Journal of Surgical Oncology
researchProduct

Cancer de l’endomètre. Application des recommandations de 2010 : étude multicentrique

2014

Resume Introduction Le cancer de l’endometre est le plus frequent des cancers gynecologiques. Afin d’ameliorer et d’homogeneiser les prises en charge du cancer de l’endometre, des recommandations ont ete elaborees en novembre 2010. Le but de cette etude est d’evaluer l’application de ces recommandations. Materiel et methode Notre etude multicentrique retrospective utilise les bases de donnees de trois centres francais : le CHU de Reims, l’Hopital Tenon de Paris et le Centre de lutte contre le cancer Georges-Francois-Leclerc de Dijon de novembre 2010 a decembre 2012. Cette etude consistait en l’evaluation des modalites de prise en charge diagnostique et therapeutique des patientes presentant…

GynecologyCancer Researchmedicine.medical_specialtyOncologybusiness.industryMedicineRadiology Nuclear Medicine and imagingHematologyGeneral MedicinebusinessBulletin du Cancer
researchProduct